|
|
||||||||





Departments of
*
Immunology and
Molecular Biology, and
The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037
Susceptibility to insulin-dependent diabetes mellitus is linked to
MHC class II genes. The only MHC class II molecule expressed by
nonobese diabetic (NOD) mice, I-Ag7, shares a common
-chain with I-Ad but has a peculiar ß-chain. As with
most ß-chain alleles linked to diabetes susceptibility,
I-Ag7 contains a nonaspartic residue at position ß57. We
have produced large amounts of empty I-Ag7 molecules using
a fly expression system to characterize its biochemical properties and
peptide binding by phage-displayed peptide libraries. The
identification of a specific binding peptide derived from glutamic acid
decarboxylase (GAD65) has allowed us to crystallize and obtain the
three-dimensional structure of I-Ag7. Structural
information was critical in evaluating the binding studies.
I-Ag7, like I-Ad, appears to be very
promiscuous in terms of peptide binding. Their binding motifs are
degenerate and contain small and/or small hydrophobic residues at P4
and P6 of the peptide, a motif frequently found in most globular
proteins. The degree of promiscuity is increased for I-Ag7
over I-Ad as a consequence of a larger P9 pocket that can
specifically accommodate negatively charged residues, as well as
possibly residues with bulky side chains. So, although I-Ad
and I-Ag7 are structurally closely related, stable
molecules and good peptide binders, they differ functionally in their
ability to bind significantly different peptide repertoires that are
heavily influenced by the presence or the absence of a negatively
charged residue at position 57 of the ß-chain. These characteristics
link I-Ag7 with autoimmune diseases, such as
insulin-dependent diabetes mellitus.
This article has been cited by other articles:
![]() |
N. Ishimaru, R. Arakaki, S. Yoshida, A. Yamada, S. Noji, and Y. Hayashi Expression of the retinoblastoma protein RbAp48 in exocrine glands leads to Sjogren's syndrome-like autoimmune exocrinopathy J. Exp. Med., November 24, 2008; 205(12): 2915 - 2927. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Tian, M. J. I. Ansari, J. Paez-Cortez, J. Bagley, J. Godwin, M. Donnarumma, M. H. Sayegh, and J. Iacomini Induction of Robust Diabetes Resistance and Prevention of Recurrent Type 1 Diabetes Following Islet Transplantation by Gene Therapy J. Immunol., November 15, 2007; 179(10): 6762 - 6769. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gardiner, K. A. Richards, A. J. Sant, and L. S. Arneson Conformation of MHC class II I-Ag7 is sensitive to the P9 anchor amino acid in bound peptide Int. Immunol., September 1, 2007; 19(9): 1103 - 1113. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Levisetti, A. Suri, S. J. Petzold, and E. R. Unanue The Insulin-Specific T Cells of Nonobese Diabetic Mice Recognize a Weak MHC-Binding Segment in More Than One Form J. Immunol., May 15, 2007; 178(10): 6051 - 6057. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Mellanby, C. H. Koonce, A. Monti, J. M. Phillips, A. Cooke, and E. K. Bikoff Loss of Invariant Chain Protects Nonobese Diabetic Mice against Type 1 Diabetes J. Immunol., December 1, 2006; 177(11): 7588 - 7598. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Bill, D. G. Mack, M. T. Falta, L. A. Maier, A. K. Sullivan, F. G. Joslin, A. K. Martin, B. M. Freed, B. L. Kotzin, and A. P. Fontenot Beryllium Presentation to CD4+ T Cells Is Dependent on a Single Amino Acid Residue of the MHC Class II {beta}-Chain J. Immunol., November 15, 2005; 175(10): 7029 - 7037. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Smith, T. Patterson, and M. E. Pauza Transgenic Ly-49A Inhibits Antigen-Driven T Cell Activation and Delays Diabetes J. Immunol., April 1, 2005; 174(7): 3897 - 3905. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Carven, S. Chitta, I. Hilgert, M. M. Rushe, R. F. Baggio, M. Palmer, J. E. Arenas, J. L. Strominger, V. Horejsi, L. Santambrogio, et al. Monoclonal Antibodies Specific for the Empty Conformation of HLA-DR1 Reveal Aspects of the Conformational Change Associated with Peptide Binding J. Biol. Chem., April 16, 2004; 279(16): 16561 - 16570. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zavala-Ruiz, E. J. Sundberg, J. D. Stone, D. B. DeOliveira, I. C. Chan, J. Svendsen, R. A. Mariuzza, and L. J. Stern Exploration of the P6/P7 Region of the Peptide-binding Site of the Human Class II Major Histocompatability Complex Protein HLA-DR1 J. Biol. Chem., November 7, 2003; 278(45): 44904 - 44912. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-H. Jang, N. P. Seth, and K. W. Wucherpfennig Ex Vivo Analysis of Thymic CD4 T Cells in Nonobese Diabetic Mice with Tetramers Generated from I-Ag7/Class II-Associated Invariant Chain Peptide Precursors J. Immunol., October 15, 2003; 171(8): 4175 - 4186. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Jaeckel, L. Klein, N. Martin-Orozco, and H. von Boehmer Normal Incidence of Diabetes in NOD Mice Tolerant to Glutamic Acid Decarboxylase J. Exp. Med., June 16, 2003; 197(12): 1635 - 1644. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cantu III, K. Benlagha, P. B. Savage, A. Bendelac, and L. Teyton The Paradox of Immune Molecular Recognition of {alpha}-Galactosylceramide: Low Affinity, Low Specificity for CD1d, High Affinity for {alpha}{beta} TCRs J. Immunol., May 1, 2003; 170(9): 4673 - 4682. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Suri, J. J. Walters, O. Kanagawa, M. L. Gross, and E. R. Unanue Specificity of peptide selection by antigen-presenting cells homozygous or heterozygous for expression of class II MHC molecules: The lack of competition PNAS, April 29, 2003; 100(9): 5330 - 5335. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Starwalt, E. L. Masteller, J. A. Bluestone, and D. M. Kranz Directed evolution of a single-chain class II MHC product by yeast display Protein Eng. Des. Sel., February 1, 2003; 16(2): 147 - 156. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sidney, M.-F. del Guercio, S. Southwood, and A. Sette The HLA Molecules DQA1*0501/B1*0201 and DQA1*0301/B1*0302 Share an Extensive Overlap in Peptide Binding Specificity J. Immunol., November 1, 2002; 169(9): 5098 - 5108. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. V. Tarbell, M. Lee, E. Ranheim, C. C. Chao, M. Sanna, S.-K. Kim, P. Dickie, L. Teyton, M. Davis, and H. McDevitt CD4+ T Cells from Glutamic Acid Decarboxylase (GAD)65-specific T Cell Receptor Transgenic Mice Are Not Diabetogenic and Can Delay Diabetes Transfer J. Exp. Med., August 19, 2002; 196(4): 481 - 492. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wen, F. S. Wong, R. Sherwin, and C. Mora Human DQ8 Can Substitute for Murine I-Ag7 in the Selection of Diabetogenic T Cells Restricted to I-Ag71 J. Immunol., April 1, 2002; 168(7): 3635 - 3640. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Suri, I. Vidavsky, K. van der Drift, O. Kanagawa, M. L. Gross, and E. R. Unanue In APCs, the Autologous Peptides Selected by the Diabetogenic I-Ag7 Molecule Are Unique and Determined by the Amino Acid Changes in the P9 Pocket J. Immunol., February 1, 2002; 168(3): 1235 - 1243. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Monneaux, H. Dumortier, G. Steiner, J.-P. Briand, and S. Muller Murine models of systemic lupus erythematosus: B and T cell responses to spliceosomal ribonucleoproteins in MRL/Faslpr and (NZB NZW)F1 lupus mice Int. Immunol., September 1, 2001; 13(9): 1155 - 1163. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kelemen, D. R. Wegmann, and J. C. Hutton T-Cell Epitope Analysis on the Autoantigen Phogrin (IA-2{beta}) in the Nonobese Diabetic Mouse Diabetes, August 1, 2001; 50(8): 1729 - 1734. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |